Rockefeller Capital Management
TPTX

Rockefeller Capital Management’s Turning Point Therapeutics, Inc. Common Stock TPTX Stock Holding History

Rockefeller Capital Management’s Portfolio TPTX Stock Details TPTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-15
Closed -$1K – 4601
2022
Q2 		$1K Buy
15
+1
+7% +$44 ﹤0.01% 4068
2022
Q1 		$0 Sell
14
-1
-7% -$34 ﹤0.01% 4182
2021
Q4 		$0 Buy
+15
New +$671 ﹤0.01% 4091
2021
Q3 		– Sell
-17
Closed -$1K – 3927
2021
Q2 		$1K Buy
+17
New +$1.26K ﹤0.01% 3408

Rockefeller Capital Management's TPTX Position: Q3 2022 in Review

Rockefeller Capital Management sold out of Turning Point Therapeutics, Inc. Common Stock (TPTX) in Q3 2022, closing a stake of 15 shares — an estimated $1K sold.

Rockefeller Capital Management first reported a position in TPTX in Q2 2021 and held it in 4 quarters. The position peaked at $1K in Q2 2022. 0 funds tracked by Wall St. Rank hold TPTX as of Q3 2022.

  • Rockefeller Capital Management reported no remaining Turning Point Therapeutics, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • Rockefeller Capital Management sold 15 Turning Point Therapeutics, Inc. Common Stock shares in Q3 2022, an estimated $1K.
  • Rockefeller Capital Management first reported a position in Turning Point Therapeutics, Inc. Common Stock in Q2 2021 and held it in 4 quarters.
  • Rockefeller Capital Management's Turning Point Therapeutics, Inc. Common Stock position peaked at $1K in Q2 2022.
  • 0 funds tracked by Wall St. Rank held Turning Point Therapeutics, Inc. Common Stock as of Q3 2022.

Based on Rockefeller Capital Management's 13F filing for Q3 2022, filed 2 Nov 2022.